Clinical Trials Logo
  1. Home
  2. Venous Disease
  3. NCT04358497

Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome — ENDPCS  

Venous Disease Clinical Trial

Official title:
Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome

Clinical Trial Summary

Compare the efficacy and safety of endovascular treatment with sandwich technique (controlled release coils and 2% polidocanol foam) associated with diosmin-hisperidine and ibuprofen medical treatment and only the best chronic medical treatment available diosmin-hisperidine and ibuprofen for 3 months, in women of active gynecological age carrying pelvic congestion syndrome in public assistance in Montevideo, Uruguay.

Clinical Trial Description

Pelvic congestion syndrome (PCS) is a recognized and frequent cause of Chronic Pelvic Pain (10% to 30%). It is defined as the presence of chronic symptoms, which may include pelvic pain, perineal heaviness, urinary urgency and postcoital pain, caused by reflux and / or obstruction of the gonadic and / or pelvic veins, and that may be associated with vulvar, perineal and lower limbs varicose veins.

There is no standard approach to managing PCS. According to expert recommendations, therapies should be individualized according to the patient's symptoms and needs.

Medical treatment options include progestagens, danazol, combined oral hormonal contraceptives, phlebotonics such as hisperidine-added diosmin, non-steroidal anti-inflammatory drugs and gonadotropin-releasing hormone (GnRH) agonists

Currently, the only accepted chronic medical treatment is the association of non-steroidal and phlebotonic anti-inflammatories, but they have shown a poor symptomatic benefit in reducing pain.

Surgical treatment has evolved over time mainly in the hands of laparoscopic techniques, currently the endovascular option is the most widely accepted for presenting excellent long-term results with abolition of pain in up to 90% at 2 years.

HYPOTHESIS

Endovascular treatment of pelvic congestion syndrome is better in terms of pain control and quality of life compared to drug treatment.

General objective

Compare the efficacy and safety of endovascular treatment with sandwich technique (controlled release coils and 2% polidocanol foam) associated with diosmin-hisperidine and ibuprofen medical treatment and only the best chronic medical treatment available diosmin-hisperidine and ibuprofen for 3 months, in women of active gynecological age carrying pelvic congestion syndrome in public assistance in Montevideo, Uruguay.

Specific objectives

• Compare pain in patients undergoing endovascular treatment with the best

medical treatment.

- Evaluate the persistence of pelvic varices in patients undergoing endovascular treatment of SCP.

- Compare the Female Sexual Satisfaction Index in both groups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04358497
Study type Interventional
Source Hospital de Clínicas Dr. Manuel Quintela
Contact Sebastian Sarutte, VS
Phone +59899533449
Email ssarutte1@hotmail.com
Status Not yet recruiting
Phase Phase 4
Start date October 1, 2020
Completion date October 1, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05633277 - Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections N/A
Completed NCT04758728 - Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping N/A
Recruiting NCT05409976 - The GORE® VIAFORT Vascular Stent IVC Study N/A
Completed NCT06395025 - Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Comparison With a Control Group N/A
Completed NCT03703765 - Volume Estimation of the Limb After VEnous Treatment N/A
Completed NCT01368159 - Efficacy on Pain Following a Procedure for Injecting Sclerotherapeutic Foam Into the Great Saphenous Vein Phase 4
Recruiting NCT05628948 - Vascular Lab Resource (VLR) Biorepository
Completed NCT06153680 - Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return N/A
Terminated NCT03363633 - Perforator Vein Injection for Symptomatic Venous Disease N/A
Recruiting NCT05489588 - The GORE® VIAFORT Vascular Stent Iliofemoral Study N/A
Not yet recruiting NCT06433024 - Training of a Artificial Intelligence Model to Detect Venous Diseases Using PPG Technology
Completed NCT02655887 - BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease N/A
Recruiting NCT05050799 - US Post-Market Surveillance Study of the Surfacer System
Completed NCT01993914 - Prevalence of MTHFR Polymorphisms in Venous Disease N/A
Active, not recruiting NCT04138134 - Autophagy and Venous Endothelial Function
Terminated NCT04964817 - HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease Study
Recruiting NCT02139085 - Great Saphenous Vein Electrocoagulation Phase 2
Completed NCT01509599 - Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation Phase 1/Phase 2
Terminated NCT03630185 - A Comparison of Custom-manufactured vs. Off-the-rack (OTR) Compression Hosiery for Initial Management of Venous Disease N/A